Unlock instant, AI-driven research and patent intelligence for your innovation.

A novel interferon α1 and its preparation method, composition and application

A technology for interferon alpha and composition, applied in the field of novel interferon alpha 1 and its preparation, can solve the problems of poor stability, low specific activity of IFN-alpha 1b, limited popularization and application, etc., and achieve high biological activity and stability Effect

Active Publication Date: 2019-10-18
SHENZHEN LIYUNDE BIOTECH CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, the low specific activity and poor stability of IFN-α1b limit its further clinical application.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A novel interferon α1 and its preparation method, composition and application
  • A novel interferon α1 and its preparation method, composition and application
  • A novel interferon α1 and its preparation method, composition and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Example 1: Construction of novel interferon α1 expressing engineered bacteria and confirmation of expression sequence

[0024] Synthesize the corresponding nucleic acid template according to the SEQ ID No.1 of the sequence list, and amplify a sufficient amount of nucleic acid by PCR.

[0025] The primers of the amplification reaction system are:

[0026] F: CATATGATGGTTTCTACCTGC

[0027] R: CTCGAGCGTGAACAGCTTAACT

[0028] The amplification reaction system includes: 1 μl of dNTP, 5 μl of 10X pfu buffer, 2 μl of upstream and downstream primers, 1 μl of client template, 0.4 μl of Pfu enzyme (5u / μl), and 38.6 μl of ddH2O.

[0029] The amplification reaction conditions are: 95° C. for 3 minutes, 95° C. for 22 seconds, 68° C. for 20 seconds, 72° C. for 60 seconds, and 72° C. for 5 minutes. A total of 24 cycles. After the reaction is completed, use agarose gel electrophoresis to separate, digest with Nde I / Xho I, and recover the target DNA fragment of about 500 bp by elect...

Embodiment 2

[0033] Example 2: Fermentation, purification and detection of novel interferon α1

[0034] The expression engineered bacterium of the novel interferon α 1 constructed in the foregoing embodiment 1 is activated by smearing a plate and selecting a single colony to be inoculated in the LB medium containing kanamycin with a final concentration of 30 μg / mL (use 10 g of peptone per liter, Prepared with 5 g of yeast powder and 10 g of NaCl, adjusted to pH 7.0), cultured in a shaker flask at 37°C and 230 rpm until OD600nm was 0.6-0.8. Then inoculate in the LB substratum of 50L with the volume inoculum of 5% and carry out fermentation culture (contain the kanamycin of 30 μ g / mL) in 80L fermenter, culture temperature is 37 ℃, adjusts pH with ammoniacal liquor in the cultivation process Between 6.5-7.5, use the speed to control the dissolved oxygen value between 3-5%. After OD600nm reached 1.0, 10 g of IPTG was added at a mass volume ratio of 1:5000 to continue the induction culture for...

Embodiment 3

[0040] Embodiment 3: Stability test of novel interferon α1

[0041] The novel interferon α1 obtained by the purification of the foregoing Example 2 was placed at room temperature (25° C.) for 3 months, and samples were regularly taken during this process to observe changes in appearance, and to detect purity and biological activity (using "Pharmacopoeia of the People's Republic of China") The changes in the main quality control indicators such as the "Interferon Activity Assay Method" stipulated in the 2015 Edition (Part Three), the results are shown in Table 1 below. Table 2 shows the corresponding IFN-α1b stability test results at 25°C.

[0042] Table 1 25°C Stability Test Results of Novel Interferon α1

[0043]

[0044] Table 2 Stability test results of IFN-α1b at 25°C

[0045]

[0046]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of biotech drugs and relates to a novel interferon alpha 1 as well as a preparation method, a composition and an application of the novel interferon alpha1. The novel interferon alpha 1 has an amino acid sequence as shown in SEQ ID No.1. The novel interferon alpha 1 disclosed by the invention has obviously higher bioactivity and stability on the basisthat the good safety and drug effect can be kept.

Description

technical field [0001] The invention belongs to the technical field of biotechnology drugs, and relates to a novel interferon alpha 1 and its preparation method, composition and application. Background technique [0002] Interferon (interferon, IFN) is a class of cytokine protein drugs with broad-spectrum antiviral, antitumor and immunomodulatory effects, including type I, type II and type III, which have different receptors and functions. A key component of the body's natural immune system. Among them, type I IFN was discovered in 1957. It is an important antiviral substance produced by humans and animals after being infected by viruses. κ, IFN-ω, etc. Three subtypes of IFN-α have been approved for clinical use as drugs, namely IFN-α1b, IFN-α2a and IFN-α2b, all of which are genetically recombined products. The IFN-α used abroad is mainly IFN-α2a and IFN-α2b, whose genes are derived from Western Caucasians; the IFN-α used in my country is mainly IFN-α1b, whose gene was ob...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/56C12N15/21C12N15/70A61K38/21A61P31/12A61P1/16A61P31/14
CPCA61K38/00A61P1/16A61P31/12A61P31/14C07K14/56C12N15/70Y02A50/30
Inventor 侯云德张莉唐旭东周敏毅李华
Owner SHENZHEN LIYUNDE BIOTECH CO LTD